Risk factors of tigecycline-associated fibrinogen reduction in patients with renal transplantation: a case-control study

BACKGROUND: Hypofibrinogenemia is a serious adverse reaction related to tigecycline administered against multidrug-resistant (MDR) bacteria and can lead to therapy termination. High dose and prolonged tigecycline therapy, renal failure, and base level of fibrinogen (FIB) were reported risk factors o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Wenqing, Ma, Kuifen, Xu, Zhuoyun, Xie, Jiao, Lu, Xiaoyang, Wang, Xiaojuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641064/
https://www.ncbi.nlm.nih.gov/pubmed/36386261
http://dx.doi.org/10.21037/tau-22-522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641064/
https://www.ncbi.nlm.nih.gov/pubmed/36386261
http://dx.doi.org/10.21037/tau-22-522

Ejemplares similares